Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE: BWEL.U) is pleased to announce that its subsidiary company, One Plant Florida (“One Plant”), has opened a new retail dispensary and delivery hub location in Bonita Springs, Florida on March 17. The new location marks the Company’s eighth location in the State of Florida.
Situated in the heart of Lee County, One Plant’s Bonita Springs retail dispensary and delivery hub will serve qualified patients throughout the greater Naples area. The new hub is located at 28500 Bonita Crossing, Bonita Springs, FL 34135.
One Plant is an emerging player in Florida’s cannabis market with a sharp focus on extraordinary patient care. One Plant was the first company in Florida to build and launch its own e-commerce platform. It was also Florida’s first next-day e-commerce home delivery service. It also offers curbside pickup at all retail locations.
“We are proud to open our Bonita Springs dispensary and delivery hub, allowing us to provide our patients with convenient access to premium flower in Lee County and the surrounding Naples area,” said Brady Cobb, Chief Executive Officer of Bluma Wellness and One Plant Florida. “At One Plant, we’ve carefully selected our retail sites to promote speedy delivery and we look forward to further expanding our home delivery and curbside pickup network throughout Florida.”
The Bonita Springs location will offer access to One Plant’s top-shelf genetics, hang-dried and hand-trimmed flower, vape products, concentrates and merchandise through an in-store experience, curbside pickup or home delivery. Offerings include prime and rare strains of cannabis flower and pre rolls including Mac1, Runtz, London Pound Cake, Blueberry Muffin, Dirty Lemons, ChemD, Fish Whistle, Apple Fritter, Marshmallow OG, Watermelon Gushers, and I75, among others.
One Plant also offers premium solventless ice hash products including live rosin, bubble hash, live rosin jam, fresh press jam, live rosin vaporizer cartridges, as well as traditional distillate products including vaporizer cartridges, tinctures, and topicals.
To utilize One Plant’s robust delivery and curbside options at its retail locations, orders can be placed online, and patients can use CanPay for payment. Patients must have a medical marijuana card to purchase products.
Qualified patients can learn more about the Company’s retail dispensary locations by visiting www.oneplant.us.
About Bluma Wellness Inc.: Bluma Wellness Inc. owns and operates a vertically-integrated, licensed medical cannabis company in the State of Florida doing business as “One Plant Florida.” One Plant Florida cultivates, processes, dispenses and retails medical cannabis to qualified patients in the State of Florida through multiple retail dispensaries and an innovative next-day door-to-door e-commerce home delivery service, thereby offering convenient access for its patients and meeting the demands of an evolving retail landscape. Bluma plans to continue expanding its cultivation and distribution operations as the Florida market grows and may enter into other US states where the production, distribution and use of cannabis is permitted under state law. For more information, visit www.blumawellness.com or www.oneplant.us.
The Company’s securities have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States or to a U.S. Person absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws including information relating to the opening of One Plant’s Bonita Springs retail and delivery hub and the Company’s strategic business plans. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements due to a variety of known and unknown risks and uncertainties including, without limitation: risks relating to cannabis being illegal under US federal law and risks of US federal enforcement actions related to cannabis activities; the Company’s ability to comply with all applicable governmental regulations in a highly regulated business; negative changes in the political environment or in the regulation of medical cannabis in the state of Florida; the risk of any disruptions to the Company’s business and operations as a result of the COVID-19 pandemic; negative shifts in public opinion and perception of the cannabis industry and cannabis consumption; increasing competition in the industry; risks of product liability and other safety-related liability as a result of usage of the Company’s cannabis products; the Company’s limited operating history with no assurance of profitability; the ability of the Company to access future financing if needed or on terms acceptable to the Company; the risk of defaulting on its existing debt; risk of shortages of or price increases in key inputs, suppliers and skilled labor; the risks inherent in running agricultural operations such as pests and crop failure; loss of licenses; reliance on key personnel; cybersecurity risks; constraints on marketing products; fraudulent activity by employees, contractors and consultants; tax and insurance related risks and risk of litigation.
The forward-looking information in this press release are made as of the date of this release. The Company does not undertake any obligation to update forward-looking information except as required by applicable securities laws.